Ziresovir

齐瑞索韦

Report date: 2026/02/11 20:01:36
NME

Base Information

Drug NameZiresovir
Drug Alias NameZiresovir - Ark Biosciences爱司韦RO-0529AK-0529
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionRespiratory syncytial virus F protein inhibitors
TargetsRespiratory syncytial virus F protein
Therapy Area/IndicationsRespiratory Syncytial Virus Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesTaiwanPoland +[11] 
CombinationsNo
Global Highest StatusNDA/BLA
Highest Status in ChinaNDA/BLA
Originator CompaniesF. Hoffmann-La Roche Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesShanghai Ark Biopharmaceutical Co Ltd
Inactive CompaniesArk Biosciences Pty Ltd
Active IndicationsRespiratory Syncytial Virus Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A